×

Access Whitepaper

First Name
Last Name
Phone Number
Thank you!
Error - something went wrong!
   

Returning Study Results to Research Participants

Studies show that most clinical trial participants want to know what was learned from their involvement. A growing number of sponsors are implementing plans to deliver plain language summaries to trial participants.  

Read this white paper, co-authored by the Center for Information and Study of Clinical Research Participation (CISCRP) to learn about the current best practices for the content and preparation of plain language summaries, and the current guidance for how sponsors should work with Institutional Review Boards (IRBs) which have oversight of the clinical trials for which the summaries are provided.
 

About the Author

David Forster, JD, MA, CIP | Chief Compliance Officer

Mr. Forster has a J.D. and a Masters in Medical Ethics from the University of Washington. He joined Western IRB (WIRB) in 1996 and is currently the Chief Compliance Officer for the WIRB-Copernicus Group (WCG). Mr. Forster co-chairs the Secretary’s Advisory Committee on Human Research Protections (SACHRP) Sub-Committee on Harmonization (SOH). He previously served a four-year term as a member of SACHRP, and was a member of the SACHRP Sub-Committee on Inclusion of Individuals with Impaired Decision-Making in Research (SIIIDR). Mr. Forster also serves on the Certified IRB Professional (CIP) Council.

Follow on Linkedin More Content by David Forster, JD, MA, CIP | Chief Compliance Officer
Previous Flipbook
Precision Medicine: A Glossary of Terms
Precision Medicine: A Glossary of Terms

As genetic testing becomes an integral part of clinical development programs, understanding the key terms a...

Next Flipbook
Written Procedures for IRBs: What Does the New Final Guidance from FDA and OHRP Mean to You?
Written Procedures for IRBs: What Does the New Final Guidance from FDA and OHRP Mean to You?

Request a Genetics in Clinical Trials training session

What You'll Learn